Skip to main content

Journal of Cancer Research and Clinical Oncology

Ausgabe 5/2022

Inhalt (26 Artikel)

Review – Cancer Research

Radiotherapy resistance: identifying universal biomarkers for various human cancers

Irina Larionova, Militsa Rakina, Elena Ivanyuk, Yulia Trushchuk, Alena Chernyshova, Evgeny Denisov

Review – Cancer Research

The 3D in vivo chorioallantoic membrane model and its role in breast cancer research

Cynthia Kohl, Thiha Aung, Silke Haerteis, Atanas Ignatov, Olaf Ortmann, Thomas Papathemelis

Open Access Original Article – Cancer Research

Ex vivo propagation in a novel 3D high-throughput co-culture system for multiple myeloma

Johannes M. Waldschmidt, Stefan J. Fruttiger, Dagmar Wider, Johannes Jung, Andreas R. Thomsen, Tanja N. Hartmann, Justus Duyster, Martin J. Hug, Kareem A. Azab, Manfred Jung, Ralph Wäsch, Monika Engelhardt

Open Access Original Article – Cancer Research

Prevalence of diabetes mellitus among 80,193 gastrointestinal cancer patients in five European and three Asian countries

Christoph Roderburg, Sven H. Loosen, Laura Hoyer, Tom Luedde, Karel Kostev

Original Article – Cancer Research

Estrogen concentration and estrogen receptor-β expression in postmenopausal colon cancer considering patient/tumor background

Naoko Honma, Tomio Arai, Yoko Matsuda, Yosuke Fukunaga, Yuri Akishima-Fukasawa, Noriko Yamamoto, Hiroshi Kawachi, Yuichi Ishikawa, Kengo Takeuchi, Tetuo Mikami

Original Article – Cancer Research

In vivo and in vitro inhibition of SCLC by combining dual cancer-specific recombinant adenovirus with Etoposide

Tingyu Li, Jinbo Fang, Jihao Chu, Xing Liu, Yiquan Li, Yilong Zhu, Shanzhi Li, Zhiru Xiu, Yaru Li, Ningyi Jin, Guangzhe Zhu, Lili Sun, Xiao Li

Open Access Original Article – Cancer Research

Socioeconomic disparities in endometrial cancer survival in Germany: a survival analysis using population-based cancer registry data

Ahmed Bedir, Semaw Ferede Abera, Dirk Vordermark, Daniel Medenwald

Review – Clinical Oncology

Immunotherapy maintenance therapy for advanced urothelial carcinoma (aUC): a comprehensive review

Lucia Carril-Ajuria, Maria Cruz Martin-Soberón, Guillermo de Velasco, Neeraj Agarwal, Daniel Castellano

Open Access Original Article – Clinical Oncology

Complementary and alternative medicine (CAM) supplements in cancer outpatients: analyses of usage and of interaction risks with cancer treatment

Clemens P. J. G. Wolf, Tobias Rachow, Thomas Ernst, Andreas Hochhaus, Bijan Zomorodbakhsch, Susan Foller, Matthias Rengsberger, Michael Hartmann, Jutta Huebner

Open Access Original Article – Clinical Oncology

Epithelial circulating tumor cells with a heterogeneous phenotype are associated with metastasis in NSCLC

Yujuan Zhang, Yu Men, Jianyang Wang, Puyuan Xing, Jun Zhao, Junling Li, Danfei Xu, Zhouguang Hui, Wei Cui

Original Article – Clinical Oncology

Overuse of follow-up chest computed tomography in patients with incidentally identified nodules suspicious for lung cancer

Ran Guo, Yang Zhang, Zelin Ma, Chaoqiang Deng, Fangqiu Fu, Hong Hu, Yihua Sun, Haiquan Chen

Original Article – Clinical Oncology

Multi-institutional survey of malignant pleural mesothelioma patients in the Hokushin region

Hidetaka Uramoto, Tomoya Takiguchi, Tomonobu Koizumi, Azusa Tanimoto, Ryuji Hayashi, Yozo Nakazawa, Ken-ichi Ito, Mitsutoshi Nakada, Yasuo Hirono, Yoshikazu Nishino, Seiji Yano

Original Article – Clinical Oncology

Efficacy and safety of anti-PD-1 inhibitor combined with nab-paclitaxel in Chinese patients with refractory melanoma

Jing-jing Li, Jiu-hong Wang, Ya Dingv, Dan-dan Li, Xi-zhi Wen, Jing-jing Zhao, Hang Jiang, Xing Liu, Fu-xue Huang, Xiao-shi Zhang

Original Article – Clinical Oncology

Dexa-BEAM versus MIFAP as salvage regimen for recurrent lymphoma: a prospective randomized multicenter phase II trial with a median follow-up of 14.4 years

Sabine Kürzel, André-René Blaudszun, Lilly Stahl, Regina Herbst, Frank Kroschinsky, Josef Birkmann, Annette Hänel, Kerstin Schaefer-Eckart, Gerhard Ehninger, Friedrich Fiedler, Martin Bornhäuser, Stephan Fricke, Mathias Hänel

Open Access Original Article – Clinical Oncology

Epithelial–mesenchymal transition (EMT) in vulvar cancer with and without inguinal lymph node involvement

Christine E. Brambs, Lars-Christian Horn, Meinhard Mende, Michael Höckel, Christine Eckey, Gesine Grit Ruth Hiller, Anne Kathrin Höhn

Original Article – Clinical Oncology

Hepatitis B surface antigen positivity is associated with progression of disease within 24 months in follicular lymphoma

Chieh-Lung Cheng, Wei-Quan Fang, Yu-Jen Lin, Chang-Tsu Yuan, Bor-Sheng Ko, Jih-Luh Tang, Hwei-Fang Tien

Open Access Original Article – Clinical Oncology

Short-term outcome of Ivor Lewis esophagectomy following neoadjuvant chemoradiation versus perioperative chemotherapy in patients with locally advanced adenocarcinoma of the esophagus and gastroesophageal junction: a propensity score-matched analysis

Patrick Sven Plum, Alexander Damanakis, Lisa Buschmann, Angela Ernst, Rabi Raj Datta, Lars Mortimer Schiffmann, Thomas Zander, Hans Fuchs, Seung-Hun Chon, Hakan Alakus, Wolfgang Schröder, Arnulf Heinrich Hölscher, Christiane Josephine Bruns, Marc Bludau

Original Article – Clinical Oncology

The eagle sign: a new preoperative MRI-based tool for predicting topographic correlation between craniopharyngioma and hypothalamus

ShaoYang Li, Le Yang, ZhiGao Tong, BoWen Wu, Bin Tang, ShenHao Xie, MinDe Li, Lin Zhou, ChenXing Ouyang, Xiao Wu, YouQing Yang, ChunLiang Wang, Tao Hong

Correction

Correction to: The eagle sign: a new preoperative MRI-based tool for predicting topographic correlation between craniopharyngioma and hypothalamus

ShaoYang Li, Le Yang, ZhiGao Tong, BoWen Wu, Bin Tang, ShenHao Xie, MinDe Li, Lin Zhou, ChenXing Ouyang, Xiao Wu, YouQing Yang, ChunLiang Wang, Tao Hong

Open Access Original Article – Clinical Oncology

Efficacy of single-site radiotherapy plus PD-1 inhibitors vs PD-1 inhibitors for oligometastatic non-small cell lung cancer

Peiliang Wang, Tianwen Yin, Kaikai Zhao, Jinming Yu, Feifei Teng

Letter to the Editor

Afatinib, an effective treatment for patient with lung squamous cell carcinoma harboring uncommon EGFR G719A and R776C co-mutations

Chao Han, Xuan Ding, Mengmeng Li, Ningning Luo, Yingxue Qi, Chengwei Wang

„Überwältigende“ Evidenz für Tripeltherapie beim metastasierten Prostata-Ca.

22.05.2024 Prostatakarzinom Nachrichten

Patienten mit metastasiertem hormonsensitivem Prostatakarzinom sollten nicht mehr mit einer alleinigen Androgendeprivationstherapie (ADT) behandelt werden, mahnt ein US-Team nach Sichtung der aktuellen Datenlage. Mit einer Tripeltherapie haben die Betroffenen offenbar die besten Überlebenschancen.

So sicher sind Tattoos: Neue Daten zur Risikobewertung

22.05.2024 Melanom Nachrichten

Das größte medizinische Problem bei Tattoos bleiben allergische Reaktionen. Melanome werden dadurch offensichtlich nicht gefördert, die Farbpigmente könnten aber andere Tumoren begünstigen.

CAR-M-Zellen: Warten auf das große Fressen

22.05.2024 Onkologische Immuntherapie Nachrichten

Auch myeloide Immunzellen lassen sich mit chimären Antigenrezeptoren gegen Tumoren ausstatten. Solche CAR-Fresszell-Therapien werden jetzt für solide Tumoren entwickelt. Künftig soll dieser Prozess nicht mehr ex vivo, sondern per mRNA im Körper der Betroffenen erfolgen.

Blutdrucksenkung könnte Uterusmyome verhindern

Frauen mit unbehandelter oder neu auftretender Hypertonie haben ein deutlich erhöhtes Risiko für Uterusmyome. Eine Therapie mit Antihypertensiva geht hingegen mit einer verringerten Inzidenz der gutartigen Tumoren einher.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.